Ticker: COCP

Cocrystal Pharma, Inc. (NASDAQ: COCP) Short take: management cut operating spend and advanced clinical work (CDI‑988 Phase 1; CC‑42344 Phase 2a), but cash burn remains material and auditors/management flag a going‑concern-additional financing is required within 12 months. Key facts and figures (a...